Latest / Applied Clinical Trials
Breaking the Efficacy Ceiling in IBD and Beyond
Despite significant advances in treating inflammatory bowel disease (IBD) and other autoimmune conditions, many patients still fail to achieve lasting remission. In this Applied Clinical Trials podcast conversation, Kori Wallace, MD, PhD, vice president and global head of immunology clinical development at AbbVie, examines the biological complexity behind this persistent “efficacy ceiling” and the strategies being explored to move beyond incremental gains.
Speaking with Mike Christel, group managing editor, MJH Life Sciences, Wallace discusses the shift toward more stringent, tissue-based…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.